Curis
CRIS
#11024
Rank
C$0.95 M
Marketcap
C$0.49
Share price
-17.89%
Change (1 day)
-80.42%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): C-$33.22

According to Curis's latest financial reports the company's current EPS (TTM) is C-$33.52. In 2025 the company made an earnings per share (EPS) of C-$33.52 an increase over its 2024 EPS that were of C-$198.05.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$33.22-0.92%
2025C-$33.52-83.07%
2024C-$198.05-22.15%
2023C-$254.39-26.17%
2022C-$344.5522.3%
2021C-$281.72-25.37%
2020C-$377.51-30.93%
2019C-$546.54-2.02%
2018C-$557.81
2016C-$1,268-10%
2015C-$1,409138.1%
2014C-$591.6240%
2013C-$422.58-25%
2012C-$563.4466.67%
2011C-$338.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.85-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$5.01-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.51-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$4.41-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$6.00-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C-$7.10-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C-$0.24-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA